β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure

Abstract

Nebivolol was effective in reducing cardiac ischaemic events in patients with HF of ischaemic aetiology. The prevention of ischaemic events can be an additional beneficial effect of β-blockade in HF patients with underlying CAD.